# A Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF-03882845 In Healthy Volunteers

> **NCT00971802** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 50 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** PF-03882845 or Placebo
- **DRUG:** PF-03882845 or Placebo
- **DRUG:** PF-03882845 or Placebo
- **DRUG:** PF-03882845 or Placebo

## Key facts

- **NCT ID:** NCT00971802
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2010-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00971802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00971802, "A Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF-03882845 In Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00971802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*